Endometrial cancer, or cancer of the uterine lining, is the most common cancer of the female reproductive system, affecting roughly 40,000 women each year. However, it is also one of the most survivable gynecological cancers, if diagnosed early and properly treated.
Methodist Obstetrics and Gynecology Group is a leader in the treatment of endometrial cancer. With revolutionary surgical and medical techniques, ground-breaking clinical trials and a highly-trained, caring staff, we provide you with the most complete course of therapy and the fastest recovery time for your particular condition.
At Methodist, we offer you the latest in treatment options in an atmosphere of respect and compassion. We treat you, the person – not just your disease – to improve both your prognosis and your quality of life. To find more information on some of our state-of-the-art methods for treating endometrial cancer, please visit the links below.
- Laparoscopic Treatment
- Robotic-Assisted Surgery
- Clinical Trials for Endometrial Cancer
- Multidisciplinary Approach to Endometrial Cancer Treatment
- Genetic Testing
In the surgical treatment of endometrial cancer, laparoscopic surgery is a great improvement over the methods of the past. Rather than requiring a large abdominal incision, which can slow recovery time and increase pain after surgery, laparoscopic surgery is minimally invasive, often involving incisions of only one inch in length or less. Through these small incisions, your surgeon uses a special narrow tool called a laparoscope to view and remove areas of disease, with a small camera to guide the surgical device. Although this treatment is most often used for minor procedures, hysterectomies are able to be performed through laparoscopic treatment, with only half the recovery time of traditional, invasive abdominal surgery.
One of the most innovative technologies being used in medicine today is robotic-assisted surgery. The da Vinci® Surgical System offers unprecedented precision while using only the smallest of incisions, making this a tremendous breakthrough for major surgeries. Using this system, your surgeon will have greater control over his or her movements while also working with a highly magnified 3-D image of the area to be operated upon. This level of accuracy leads to fewer complications, even if you have had previous abdominal surgeries and/or internal scarring (often an issue in traditional surgery), and results in a far more rapid recovery time than offered by other forms of surgery.
The da Vinci System does not perform the surgery on its own, but is instead a highly advanced tool used in real time by your skilled surgeon, much like any other piece of surgical equipment. The Methodist Hospital has four of these systems available for surgery – more than any other hospital in the area.
Methodist Obstetrics and Gynecology Group is currently conducting clinical trials to determine the effectiveness of new types of chemotherapy on endometrial cancer. If you are interested in being a participant, please visit our Clinical Trials section for more information about this study, speak with your physician regarding your interest in the study and contact Dr. Carol Hodgson at 713-441-6616 to find out if you meet the criteria for participation.
We invite you to learn more about our clinical trials, including the types of trials we conduct, the benefits of participation and our commitment to patient safety.
After a diagnosis of cancer, you may be overwhelmed by all the steps to be taken and specialists to see on your road to wellness. Methodist’s multidisciplinary care helps you – and those who are treating you – by creating a cancer care “team” working and communicating closely with each other. Your team will be composed of your physicians, oncologists and specialists as well as those providing emotional and spiritual care (such as therapists and chaplains). As a group, your caregivers are able to not only devise the best possible treatment plan for your needs, but they can provide an ever-important means of support to you in your treatment and recovery.
Recent studies have shown that there is a link between a condition known as hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch Syndrome, and endometrial cancer. HNPCC is caused by a genetic mutation and greatly increases the risk of many cancers, especially colorectal and endometrial. Having HNPCC can increase a woman’s lifetime risk of developing endometrial cancer to more than 70%.
Methodist Obstetrics and Gynecology Group’s revolutionary approaches to treatment include the option of genetic testing. Those who would benefit from this test are individuals with a strong family history of endometrial or colorectal cancer, particularly early-onset cancer (cancer which developed before age 50). If you have a potentially high risk for endometrial cancer, your physician may recommend testing so as to determine an appropriate prevention plan.